Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
323.98
-7.25 (-2.19%)
At close: Apr 1, 2025, 4:00 PM
331.44
+7.46 (2.30%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Madrigal Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-465.89-373.63-295.35-241.85-202.24
Upgrade
Depreciation & Amortization
1.10.530.470.410.47
Upgrade
Other Amortization
2.092.410.8--
Upgrade
Stock-Based Compensation
79.8849.7431.6326.8720.73
Upgrade
Other Operating Activities
-0.4----
Upgrade
Change in Accounts Receivable
-53.82----
Upgrade
Change in Inventory
-34.07----
Upgrade
Change in Accounts Payable
15.564.212.4520.36-0.16
Upgrade
Change in Other Net Operating Assets
-0.01-7.4935.1510.2923.64
Upgrade
Operating Cash Flow
-455.57-324.23-224.86-183.92-157.56
Upgrade
Capital Expenditures
-1.46-1.48-0.22-0.21-0.33
Upgrade
Sale (Purchase) of Intangibles
-5----
Upgrade
Investment in Securities
-267.92-501.04206.9-4.85160.11
Upgrade
Investing Cash Flow
-274.39-502.52206.69-5.06159.78
Upgrade
Long-Term Debt Issued
-6550--
Upgrade
Total Debt Issued
-6550--
Upgrade
Net Debt Issued (Repaid)
-6550--
Upgrade
Issuance of Common Stock
735.06530.48264.34171.245.09
Upgrade
Other Financing Activities
--0.36-0.89--
Upgrade
Financing Cash Flow
735.06595.12313.45171.245.09
Upgrade
Net Cash Flow
5.1-231.63295.28-17.747.31
Upgrade
Free Cash Flow
-457.03-325.71-225.07-184.13-157.9
Upgrade
Free Cash Flow Margin
-253.72%----
Upgrade
Free Cash Flow Per Share
-21.48-17.43-13.13-11.13-10.22
Upgrade
Levered Free Cash Flow
-296.99-192.38-115.68-94.62-86.74
Upgrade
Unlevered Free Cash Flow
-289.91-186.85-114-94.62-86.74
Upgrade
Change in Net Working Capital
53.25-2.17-37.61-29.87-21.56
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q